John Lehmann

5.4k total citations · 1 hit paper
75 papers, 4.5k citations indexed

About

John Lehmann is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, John Lehmann has authored 75 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Cellular and Molecular Neuroscience, 43 papers in Molecular Biology and 8 papers in Pharmacology. Recurrent topics in John Lehmann's work include Neuroscience and Neuropharmacology Research (47 papers), Receptor Mechanisms and Signaling (23 papers) and Ion channel regulation and function (14 papers). John Lehmann is often cited by papers focused on Neuroscience and Neuropharmacology Research (47 papers), Receptor Mechanisms and Signaling (23 papers) and Ion channel regulation and function (14 papers). John Lehmann collaborates with scholars based in United States, Switzerland and France. John Lehmann's co-authors include H.C. Fibiger, S.Z. Langer, J.I. Nagy, B. Scatton, S. Atmadja, Michael Williams, Cindy Tsai, Paul L. Wood, Deborah E. Murphy and Jennifer Schneider and has published in prestigious journals such as Nature, Nature Biotechnology and Brain Research.

In The Last Decade

John Lehmann

72 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The nucleus basalis magnocellularis: The origin of a cholinergic projection to the neocortex of the rat

1980 522 citations John Lehmann et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John Lehmann United States	36	3.6k	2.4k	874	528	482	75	4.5k
Madelon T. Price United States	28	3.3k 0.9×	2.1k 0.9×	550 0.6×	482 0.9×	469 1.0×	43	5.6k
Henry Sershen United States	43	3.4k 1.0×	2.9k 1.2×	589 0.7×	406 0.8×	672 1.4×	164	5.4k
M J Kuhar United States	35	3.5k 1.0×	2.2k 0.9×	609 0.7×	347 0.7×	484 1.0×	56	4.8k
Peter D. Suzdak Denmark	36	4.0k 1.1×	2.6k 1.1×	598 0.7×	244 0.5×	458 1.0×	87	5.2k
C. Bræstrup Denmark	30	4.2k 1.2×	2.6k 1.1×	1.0k 1.1×	335 0.6×	390 0.8×	55	5.8k
Dorothy W. Gallager United States	39	4.3k 1.2×	1.9k 0.8×	1.6k 1.8×	330 0.6×	574 1.2×	81	5.6k
Richard F. Squires United States	30	4.1k 1.2×	2.6k 1.1×	934 1.1×	332 0.6×	427 0.9×	60	5.8k
Tage Honoré Denmark	23	4.1k 1.1×	2.9k 1.2×	609 0.7×	175 0.3×	447 0.9×	43	5.1k
L. Charles Murrin United States	35	2.6k 0.7×	2.1k 0.9×	392 0.4×	367 0.7×	505 1.0×	80	4.1k
David Bleakman United States	45	4.8k 1.3×	3.5k 1.5×	1.1k 1.2×	476 0.9×	1.0k 2.2×	94	6.5k

Countries citing papers authored by John Lehmann

Since Specialization

Citations

This map shows the geographic impact of John Lehmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Lehmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Lehmann more than expected).

Fields of papers citing papers by John Lehmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Lehmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Lehmann. The network helps show where John Lehmann may publish in the future.

Co-authorship network of co-authors of John Lehmann

This figure shows the co-authorship network connecting the top 25 collaborators of John Lehmann. A scholar is included among the top collaborators of John Lehmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Lehmann. John Lehmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nair, Somnath, et al.. (1996). Cerebral uric acid increases following experimental traumatic brain injury in rat. Brain Research. 733(2). 287–291. 29 indexed citations

Lehmann, John, et al.. (1996). A Novel Microdialysis Probe Designed for Clinical Use: Potential Analytical and Therapeutic Applications. PubMed. 67. 66–69. 4 indexed citations

Jeng, Arco Y., et al.. (1996). Rat striatum contains pure population of ETB receptors. European Journal of Pharmacology. 300(3). 261–265. 8 indexed citations

Lehmann, John, et al.. (1995). Effects of putative cognition enhancers on the NMDA receptor by [3H]MK801 binding. European Journal of Pharmacology. 281(3). R11–R13. 7 indexed citations

Lehmann, John, et al.. (1993). 7-Chlorokynurenate prevents NMDA-induced and kainate-induced striatal lesions. Brain Research. 620(1). 1–6. 18 indexed citations

Lehmann, John, et al.. (1993). Kinetics of 2-Oxoglutarate Uptake by Synaptosomes from Bovine and Rat Retina and Cerebral Cortex and Regulation by Glutamate and Glutamine. Developmental Neuroscience. 15(3-5). 330–335. 6 indexed citations

Lehmann, John, et al.. (1992). Regional Distribution to Recovery of 5‐HT Levels after Administration of “Atrophins” MDMA and D, L‐Fenfluramine Stereospecificity and Comparison with 5,7‐Dihydroxytryptamine. Annals of the New York Academy of Sciences. 648(1). 291–295. 4 indexed citations

Lehmann, John, et al.. (1992). Cortical norepinephrine release elicited in situ by N-methyl-d-aspartate (NMDA) receptor stimulation: a microdialysis study. Brain Research. 599(1). 171–174. 21 indexed citations

Rao, Tadimeti S., et al.. (1990). Selective activation of dopaminergic pathways in the mesocortex by compounds that act at the phencyclidine (pcp) binding site: tentative evidence for pcp recognition sites not coupled to n-methyl-d-aspartate (nmda) receptors. Neuropharmacology. 29(3). 225–230. 70 indexed citations

10.

Rao, Tadimeti S., Helen S. Kim, John Lehmann, Louis L. Martin, & Paul L. Wood. (1989). Differential effects of phencyclidine (PCP) and ketamine on mesocortical and mesostriatal dopamine release. Life Sciences. 45(12). 1065–1072. 51 indexed citations

11.

Klockgether, Thomas, Lechosław Turski, Michael Schwarz, Karl‐Heinz Sontag, & John Lehmann. (1988). Paradoxical convulsant action of a novel non-competitiveN-methyl-d-aspartate (NMDA) antagonist, tiletamine. Brain Research. 461(2). 343–348. 31 indexed citations

12.

Tsai, Cindy, Jennifer Schneider, & John Lehmann. (1988). Trans-2-carboxy-3-pyrrolidineacetic acid (CPAA), a novel agonist at NMDA-type receptors. Neuroscience Letters. 92(3). 298–302. 25 indexed citations

13.

Boast, Carl A., Susan Gerhardt, Gary Pastor, et al.. (1988). The N-methyl-d-aspartate antagonists CGS 19755 and CPP reduce ischemic brain damage in gerbils. Brain Research. 442(2). 345–348. 214 indexed citations

14.

Lehmann, John, Cindy Tsai, & Paul L. Wood. (1988). Homocysteic Acid as a Putative Excitatory Amino Acid Neurotransmitter: I. Postsynaptic Characteristics at N‐Methyl‐D‐Aspartate‐Type Receptors on Striatal Cholinergic Interneurons. Journal of Neurochemistry. 51(6). 1765–1770. 47 indexed citations

15.

Lehmann, John, Astrid G. Chapman, Brian S. Meldrum, et al.. (1988). CGS 19755 is a potent and competitive antagonist at NMDA-type receptors. European Journal of Pharmacology. 154(1). 89–93. 48 indexed citations

16.

Tsai, Cindy, et al.. (1988). Glycine-evoked release of [3H]acetylcholine from rat striatal slices is independent of the NMDA receptor. Naunyn-Schmiedeberg s Archives of Pharmacology. 337(5). 552–5. 33 indexed citations

17.

Wood, Paul L., et al.. (1987). Antagonism of N-methyl-D-aspartate (NMDA) evoked increases in cerebellar cGMP and striatal ACh release by phencyclidine (PCP) receptor agonists; evidence for possible allosteric coupling of NMDA and PCP receptors. Canadian Journal of Physiology and Pharmacology. 65(9). 1923–1927. 44 indexed citations

18.

Braunwalder, Albert, et al.. (1986). Central phencyclidine (PCP) receptor binding is glutamate dependent: evidence for a PCP/excitatory amino acid receptor (EAAR) complex. Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States). 3 indexed citations

19.

Lehmann, John & S.Z. Langer. (1982). Muscarinic receptors on dopamine terminals in the cat caudate nucleus: Neuromodulation of [3H]dopamine release in vitro by endogenous acetylcholine. Brain Research. 248(1). 61–69. 98 indexed citations

20.

Lehmann, John. (1972). Folios of new writing. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact